Skip to main navigation Skip to search Skip to main content

mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD)

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)688-689
Number of pages2
JournalAmerican journal of hematology
Volume83
Issue number8
DOIs
StatePublished - Aug 2008

ASJC Scopus subject areas

  • Hematology

Cite this